Clinical Trials in Shangqiu, China
Locations / Shangqiu, China
Delta Trials hosts 58 clinical trials conducted in Shangqiu, China, making it a notable site of clinical research activity. These trials covering 82 medical conditions and multiple therapeutic areas, reflecting the scope and diversity of clinical research in this location. Since 2020, 1 trial in this location have been stopped, mirroring broader trends in global research activity. The trial counts on this page reflect the most recent data ingested from ClinicalTrials.gov, tracking research history across multiple versions for Shangqiu.
58
Total Trials
82
Conditions
1
Terminated since 2020
Browse by condition (82 total)
- Ischemic stroke, acute 4 trialsAll Ischemic stroke, acute trials
- Chronic hepatitis b 3 trialsAll Chronic hepatitis b trials
- Acute ischemic stroke 3 trialsAll Acute ischemic stroke trials
- Hepatocellular carcinoma 3 trialsAll Hepatocellular carcinoma trials
- Transient ischemic attack 3 trialsAll Transient ischemic attack trials
- Ischemic stroke 3 trialsAll Ischemic stroke trials
- All St segment elevation myocardial infarction trials
- Branch atheromatous disease 2 trialsAll Branch atheromatous disease trials
- Acute coronary syndrome 2 trialsAll Acute coronary syndrome trials
- All Chronic obstructive pulmonary disease trials
- Migraine 2 trialsAll Migraine trials
- Influenza 2 trialsAll Influenza trials
- St elevation myocardial infarction 2 trialsAll St elevation myocardial infarction trials
- Rotavirus infections 1 trialAll Rotavirus infections trials
- Varicella 1 trialAll Varicella trials
- Overweight and obesity 1 trialAll Overweight and obesity trials
- Pancreatic cancer 1 trialAll Pancreatic cancer trials
- Chronic kidney diseases 1 trialAll Chronic kidney diseases trials
- Community-acquired pneumonia 1 trialAll Community-acquired pneumonia trials
- All Heart failure with reduced ejection fraction trials